Ublituximab 71124-0026-01
- Manufacturer
- Samsung Biologics Co. Ltd
- Dosage Form
- Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- December 28, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ublituximab | 150 mg/6mL |
Selected Package
71124-0026-01Selected6 mL in 1 VIAL, SINGLE-DOSE (71124-0026-1)